![[刘小婷]](https://staticloudesa.ablesci.com/avatar/u/b901337a524b2f8aa312b155bd115e5c.png?v=5b0f)
Lv72
3370 积分 2022-09-21 加入
Abstract 6737: RAS inhibitors as payloads of ADCs to treat RAS-mutant tumors
27天前
已关闭
Abstract 1143: ATG-022, an antibody-drug conjugate targeting Claudin 18.2, demonstrated potent in vivo efficacy in gastric cancer patient-derived xenografts
1个月前
已关闭
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapy
1个月前
已完结
Abstract LB057: Pre-clinical characterization of IBI343, a site-specifically conjugated anti-Claundin18.2 ADC, for treating solid tumors
1个月前
已关闭
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
1个月前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
2个月前
已完结
Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
2个月前
已完结
Preliminary result of a phase Ib study: Efficacy and safety of FG-M108 plus gemcitabine and nab-paclitaxel in patients with Claudin18.2-positive, locally advanced, unresectable, or metastatic pancreatic cancer
3个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
3个月前
已完结
Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats
3个月前
已完结
皖公网安备34019202002308
